Zimmer Biomet Holdings, Inc.
Health
Performance
3.5
Risk
Sell
Buy
Curious about the Scores? Learn more.

Zimmer Biomet Holdings, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

30.06.2026
On shaky ground. Struggling to find a clear direction.
06.05.2026
Calmer waters ahead. Risk signals cooling off.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.
ZBH
Zimmer Biomet Holdings, Inc.
89.72
-1.54%
3.5
Sell
Buy
Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Zimmer Biomet Holdings, Inc. do? Business model and key facts

Get the full picture of Zimmer Biomet Holdings, Inc.: what it builds, where it operates, and how it makes money.

Zimmer Biomet Holdings, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 17000

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

shop
Company facts
Ivan Tornos
CEO
17000
Employees worldwide
shop
Performance
-3.1%
Last 12 months
-40.57%
Last 5 years
shop
Growth
$8.23B
Revenue year
$705.20M
Net income
shop
Valuation
$17.63B
Market Cap
25.26
Price/Earnings Ratio

Stocks related to Zimmer Biomet Holdings, Inc.

Selected based on industry alignment and relative market positioning.

RMD
ResMed Inc.
198.61
-0.19%
5.6
Sell
Buy
ResMed Inc.
DXCM
DexCom, Inc.
75.69
-1.25%
6.1
Sell
Buy
DexCom, Inc.
EW
Edwards Lifesciences Corporation
85.00
-0.85%
2.7
Sell
Buy
Edwards Lifesciences Corporation
SNN
Smith & Nephew plc
30.43
-0.52%
3.2
Sell
Buy
Smith & Nephew plc
ALGN
Align Technology, Inc.
175.05
-0.97%
6.7
Sell
Buy
Align Technology, Inc.

Events and news impacting Zimmer Biomet Holdings, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Zimmer Biomet Holdings, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.